Senior Key Account Manager, Mid-Atlantic – Rare Disease

BioSpace; United States; On-site; USD 190,000 - 225,000; Full time

Job summary

Dyne Therapeutics seeks a field-based Key Account Manager to plan and execute account-level engagement strategies for a defined set of priority accounts. You will collaborate with Commercial, Medical, Market Access & Patient Services, Patient Advocacy, and Marketing to deliver a coordinated customer experience and support effective pull-through.

This is a field-based role requiring residence within the territory and frequent travel by air to regional and national accounts, up to 80% of the

Qualifications

• Bachelor's degree required; advanced degree preferred.
• 8+ years of experience in biotech or pharmaceutical field roles.
• Experience in hospital/academic medical centers, strategic sales or medical-adjacent roles.
• Travel up to 80% is required for this role.

Responsibilities

• Develops and executes account plans for priority accounts and aligns engagement strategies with stakeholder needs.
• Coordinates with Commercial, Medical, Market Access & Patient Services, and Marketing to deliver a coordinated customer experience.
• Collaborates with cross-functional field partners to support aligned, timely, and compliant execution within accounts.
• Balances regional priorities with enterprise strategies and provides timely insights from the field.

Skills

Account management

Stakeholder engagement

Cross-functional collaboration

Communication

Education

Bachelor's degree

Advanced degree

Job description

Dyne Therapeutics seeks a field-based Key Account Manager to plan and execute account-level engagement strategies for a defined set of priority accounts. You will collaborate with Commercial, Medical, Market Access & Patient Services, Patient Advocacy, and Marketing to deliver a coordinated customer experience and support effective pull-through.

This is a field-based role requiring residence within the territory and frequent travel by air to regional and national accounts, up to 80% of the